Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Mouse skin can produce and process serotonin, with variations depending on hair cycle, body location, and mouse strain.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Genetically modifying a bacteria and changing its growth conditions significantly increased the production of a chemical called dipicolinic acid.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Nanoparticle systems make cancer treatment less toxic.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

Cow placenta extract has strong antioxidant effects and can delay skin aging in mice.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Drug metabolism affects how long a drug works, its interactions, activation, and toxicity, and is influenced by genetics, diet, illness, and other drugs.

Optimal storage solutions and effective additives are crucial for improving the survival of hair transplant grafts.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Natural small molecules can help treat diseases by activating or inhibiting the Wnt pathway.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Female hair loss linked to metabolic syndrome, not in males.

Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Effective treatments for common hair loss are limited and may have side effects, leading to patient disappointment and treatment discontinuation.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Physical activity, height, and smoking affect prostate cancer risk.